BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31047896)

  • 21. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
    Lin H; Shen L; Lin Q; Dong C; Maswela B; Illahi GS; Wu X
    Biomed Pharmacother; 2020 Mar; 123():109711. PubMed ID: 31884343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of lncRNA DLEU1 inhibits the tumorigenesis of oral squamous cell carcinoma via regulation of miR‑149‑5p/CDK6 axis.
    Lv T; Liu H; Wu Y; Huang W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
    Li J; Li Y; Meng F; Fu L; Kong C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
    Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
    J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
    Han Q; Li L; Liang H; Li Y; Xie J; Wang Z
    Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC00511 Promotes Osteosarcoma Tumorigenesis and Invasiveness through the miR-185-3p/E2F1 Axis.
    Xu J; Chen G; Zhang Y; Huang Z; Cheng X; Gu H; Xia J; Yin X
    Biomed Res Int; 2020; 2020():1974506. PubMed ID: 32964019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6.
    Zhu X; Li Y; Xie C; Yin X; Liu Y; Cao Y; Fang Y; Lin X; Xu Y; Xu W; Shen H; Wen J
    Int J Cancer; 2014 Sep; 135(6):1286-96. PubMed ID: 24510775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
    Li L; Shou H; Wang Q; Liu S
    Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative regulation of CDK6 expression by microRNA-126-5p and its influence on the proliferation and invasion of esophageal cancer cells.
    Gu JF; Liu SG; Pan Q; Qin F; Li YY
    Anat Rec (Hoboken); 2020 Nov; 303(11):2811-2820. PubMed ID: 31916689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
    Ding J; Yang C; Yang S
    J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA LINC00511 Acts as an Oncogene in Colorectal Cancer via Sponging miR-29c-3p to Upregulate NFIA.
    Hu Y; Zhang Y; Ding M; Xu R
    Onco Targets Ther; 2020; 13():13413-13424. PubMed ID: 33536761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer.
    Zhang J; Sui S; Wu H; Zhang J; Zhang X; Xu S; Pang D
    Cell Death Dis; 2019 Aug; 10(8):599. PubMed ID: 31395854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer.
    Zhao X; Li J; Huang S; Wan X; Luo H; Wu D
    Am J Transl Res; 2015; 7(8):1382-9. PubMed ID: 26396669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway.
    Zhao Y; Hong L
    Cancer Biother Radiopharm; 2021 Mar; 36(2):202-210. PubMed ID: 33156701
    [No Abstract]   [Full Text] [Related]  

  • 35. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.
    Guo W; Yu Q; Zhang M; Li F; Liu Y; Jiang W; Jiang H; Li H
    Aging (Albany NY); 2019 Aug; 11(15):5351-5367. PubMed ID: 31386627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA UCA1 promoted the growth of adrenocortical cancer cells via modulating the miR-298-CDK6 axis.
    Guo N; Sun Q; Fu D; Zhang Y
    Gene; 2019 Jun; 703():26-34. PubMed ID: 30935924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-29c induces G1 arrest of melanoma by targeting CDK6.
    Yang H; Shen C
    J BUON; 2019; 24(2):819-825. PubMed ID: 31128041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
    Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
    Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.